Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Cardiologist sparks fresh debate over mandatory vaccines
The cardiologist at the head of an influential CDC panel sees serious problems with modern vaccine policies. While many experts seem to disagree, one organization has jumped to his defense.
FDA shares update about CGM sensor recalls—issue now linked to 860 serious injuries
Abbott first warned the public about this problem in November. Now, for the second time in less than a month, the FDA is providing additional details.
Medtronic SVP Nina Goodheart to retire after nearly 20 years in cardiovascular care
Nina Goodheart, the president of Medtronic’s structural heart and aortic business, has announced her retirement.
Key trends in transcatheter tricuspid valve repair and replacement
The interventional treatment of tricuspid valve disease has evolved in recent years thanks to new research and critical FDA approvals. Cardiologist Ryan Kaple, MD, reviewed this trend for a new video interview.
Interventional cardiologists take on angiography-derived physiology in new expert opinion
ADP offers care teams multiple benefits not seen with traditional wire-based physiologic assessments. A roundtable of 17 expert clinicians discussed the topic at length, and their findings were used to develop a new manuscript published in JSCAI.

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.

Putting more emphasis on prevention in heart failure care

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

money gavel court lawsuit legal judge judgement

Saint Mary’s awarded $510M in damages in lawsuit against Universal Health Services

Universal Health Services was found by a jury to be liable for fraud in an alleged scheme to destabilize Saint Mary’s during the COVID-19 pandemic. The ruling includes punitive damages.

Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects

The model integrates structured EHR data spanning patient characteristics, cancer treatment, vitals, lab results, medications and prior acute care utilization to determine an individual’s risk of requiring urgent care throughout the course of their treatment.

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

FDA approves treatment of rare genetic disorder in children as young as 1 year old

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

Fraudulent nursing degree program linked to patient death in Missouri, prosecutors argue

Carleen Noreus, 51, faces allegations of running a pay-for-play nursing degree program, which may have helped unqualified people achieve licenses. Prosecutors are attempting to link the program to a medical error that killed a patient.

AI delivers helpful heart health advice—but not every time

AI-powered chatbots can be valuable resources when users have questions about cardiovascular health—but they are still far from perfect.

Mavacamten fails to boost outcomes for patients with nonobstructive HCM

The drug, already approved by the FDA to treat obstructive HCM, failed to outperform a placebo after 48 weeks.

Clinical

Cardiologist sparks fresh debate over mandatory vaccines

FDA shares update about CGM sensor recalls—issue now linked to 860 serious injuries

Medtronic SVP Nina Goodheart to retire after nearly 20 years in cardiovascular care

Key trends in transcatheter tricuspid valve repair and replacement

Interventional cardiologists take on angiography-derived physiology in new expert opinion